NEST 2
Alternative Names: NEST-2Latest Information Update: 21 Oct 2022
At a glance
- Originator Nested Therapeutics
- Class Antineoplastics; Small molecules
- Mechanism of Action Transcription factor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 18 Oct 2022 Preclinical trials in Cancer in USA (unspecified route) prior to October 2022 (Nested Therapeutics website, October 2022)